|
|
|
| Oral Hydrolyzed Protein Improve the Nutritional Status of Patients with Gastrointestinal Cancer |
|
|
|
|
Abstract Abstract：Objective To evaluate the therapeutic efficacy of oral hydrolyzed protein in the patients with gastrointestinal cancer. Methods Sixty cases of gastrointestinal cancer patients were prospectively included and then randomly divided into experimental group and control group; There were thirty cases in each group. The experimental group received routine nutritional support with daily oral 30g hydrolyzed protein; the control group only received routine nutritional support. Two groups accepted seven days continuous treatment. Hereafter we tested the related nutrition indicators and compared the differences between before and after treatment in two groups. Results During the treatment, the ratios of gastrointestinal complications in two groups were no significant difference. After nutritional support, the lymphocyte count, hemoglobin, total protein, albumin, globulin, pre-albumin, transferrin and HDL cholesterol in experimental group were higher than before treatment, but C-reactive protein was lower than before, the difference was statistically significant (P=0.031). However, compared with before treatment, only pre-albumin in control group was significant difference (P=0.028). After treatment, total protein, albumin, pre-albumin and transferrin in test group improved higher than control group (P=0.013, 0.001, 0.045, 0.048, respectively). Conclusions Common nutritional therapy, which combines with oral hydrolyzed protein in malnourished patients with gastrointestinal cancer, has a well adherence and tolerability and improves the patients' nutritional status.
|
|
|
|
|
|
| [1] |
SHI Han-ping， LIANG Xiao-xiao. Analysis of nutritional status of hospitalized patients with type 2 diabetes mellitus[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 342-345. |
| [2] |
WANG Chao-yun， DU Cheng， GUAN Xin， DU Xiao-wei， XU Zhu-xuan， ZHENG Zhen-dong. Advances in drug therapy for cancer cachexia[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 382-385. |
| [3] |
1FAN Yue-ping， 2ZHANG Tian， 2QU Qian-nuo， 3SHI Han-ping. Interpretation of expert consensus for nutritional therapy pathway of malignant tumor in China—peripheral venous catheterization[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 301-304. |
| [4] |
SUN Xue-hua， ZHOU Fu-xiang. Current problems and thinkings on the cancer metabolic modulation therapy[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 287-294. |
| [5] |
1，4 SONG Meng-meng，2CHEN Zhe-wen，3 LI Ye，1，4 SONG Chun-hua，5SHI Han-ping，6MIAO Ming-yong. Advances in anti-tumor effect of mannose[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 283-286. |
| [6] |
1YAO Ke-qing， 1WANG Su， 1CHEN Shuang， 1SUN Yan-teng， 1LIU Qing-yang， 1CHEN Tao，1LIU Xue-hui， 2CONG Ming-hua. Application of individualized nutrition diagnosis and intervention in patients with advanced cancer[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 305-309. |
|
|
|
|
2014, Vol. 1 
